Senegal’s $1 COVID-19 test kit and the race for a vaccine | Counting the Cost

What should take 10-15 years, the global scientific community hopes to cram into months. The World Health Organization (WHO) says there are 70 vaccines in the works for COVID-19, four of the most promising are already being tested.

The billions being spent now could help return the economy back to normality. There is no guarantee that any of the vaccines will work.

For now, on and off lockdowns and flare-ups of coronavirus could be the norm.

The Bill & Melinda Gates Foundation will fund the manufacturing of seven potential vaccines. Despite the fact that billions of dollars could be wasted, maybe just one or two of the vaccines will be successful. But Bill Gates argues that losing a billion is better than the global economy losing trillions of dollars.

The United States has set aside $27bn from its multitrillion-dollar stimulus package for the development of vaccines. It bet almost $500m on drugmaker Moderna to deliver its COVID-19 vaccine, which is already in trials.

Tech start-up BenevolentAI has unleashed its machine-learning power to find existing drugs that may be used in the fight against the pandemic. It has identified a rheumatoid arthritis drug from Eli Lilly that may do the job.

It is just one of many drugs that are in trials right now.

And it is not just the Western world that has the scientific know-how to beat the virus, in Senegal a laboratory has used its AIDS and Ebola experience to develop a $1 COVID-19 testing kit.

While there are no drugs to treat COVID-19, enterprising pharmaceutical companies are using existing drugs to help those seriously affected by the pathogen. CytoDyn is seeking approval for compassionate use of its drug.

Dr Nader Pourhassan, chief executive of US drugmaker CytoDyn, tells Al Jazeera about the effect of its drugs on patients facing severe and critical coronavirus symptoms.

Has OPEC lost its ability to control oil prices?

A pandemic, a global glut and a lack of storage was the perfect storm that sent US oil prices into negative territory for the first time ever.

Traders were forced to pay buyers to take oil off their hands. With oil at historic lows, the US oil industry is paying a heavy price with many companies filing for bankruptcy.

Despite OPEC’s record production cut, oil prices have fallen further. Has the oil cartel lost its ability to manage prices?

Rajat Kapoor, an oil analyst and managing director of Oil & Gas at AWR Lloyd, shares his thoughts on oil prices and the industry’s current challenges with Al Jazeera.

Should governments consider green bonds to revive pandemic-hit economies?

As the world throws out the rule book and spends trillions of dollars to avoid a total collapse of economies, is it time to consider stimulus that can carry us beyond the crisis?

The lockdown has proven, the natural world will go on without us. While many nations have targets to reduce pollution, the money tells us otherwise.

$250bn in “green bonds” were issued last year. Green bonds work in the same way as others but are specifically used for environmental and climate-related projects.

It may sound like a lot but added to what is already out there, that is less than 0.1 percent of the total government debt which stands at $9 trillion dollars worldwide.

Paul Simpson, chief executive of non-profit environmental consultancy CDP, explains green bonds and whether governments should consider using them to revive the pandemic-hit economies.

– Subscribe to our channel: http://aje.io/AJSubscribe
– Follow us on Twitter: https://twitter.com/AJEnglish
– Find us on Facebook: https://www.facebook.com/aljazeera
– Check our website: https://www.aljazeera.com/

About This Source - Al Jazeera English

The video item below is a piece of English language content from Al Jazeera. Al Jazeera is a Qatari state-funded broadcaster based in Doha, Qatar, owned by the Al Jazeera Media Network.

Recent from Al Jazeera English:

  • Japan: Sumo wrestling champion Hakuho to retire
  • Thailand’s ‘draconian’ alcohol laws in the spotlight
  • Why Lebanon is so hard to fix | Start Here
  • In This Story: COVID-19

    Covid-19 is the official WHO name given to the novel coronavirus which broke out in late 2019 and began to spread in the early months of 2020.

    Symptoms of coronavirus

    The main symptoms of coronavirus are:

    • a persistent new cough (non productive, dry)
    • a high temperature (e.g. head feels warm to the touch)
    • shortness of breath (if this is abnormal for the individual, or increased)

    Latest News about Covid-19

    Below are stories from around the globe related to the 2020 outbreak of novel Coronavirus – since the WHO gave the Covid-19 naming. Most recent items are posted nearest the top.

    5 Recent Items: COVID-19

  • WATCH: Biden receives coronavirus booster shot
  • Live: Biden receives a Covid-19 booster shot
  • Biden delivers remarks, receives COVID booster shot
  • Live: Biden delivers remarks, receives COVID booster shot
  • Watch live: Biden receives Covid booster shot
  • In This Story: Moderna

    Moderna is an American biotechnology company based in Cambridge, Massachusetts that focuses on drug discovery, drug development, and vaccine technologies based exclusively on messenger RNA.

    CEO: Stéphane Bancel (2011–)

    Stock ticker: (NASDAQ:MRNA)

    5 Recent Items: Moderna

  • Canadians try pronouncing the new COVID-19 vaccines names
  • Final Trades: Moderna, Palo Alto Networks, Umpqua Holdings & more
  • Melbourne construction worker’s desperate message after COVID mistake | 7NEWS
  • Young Canberrans lining up for their first Moderna vaccine, open for 12 to 59-year-olds | ABC News
  • What’s fueling the world’s Covid-19 vaccination disparity? | Inside Story
  • Leave a Comment

    We don't require your email address now, just your name. BUT, if you do add it, you may be notified if there are replies to your comment. Please make respectful comments, which add value, and avoid personal attacks on others. Comments failing to adhere to these guidelines will not be published.